Alterations in Polyamine Levels Induced by Phorbol Diesters and Other Agents That Promote Differentiation in Human Promyelocytic Leukemia Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1981 Feb 1

PMID 6940123

Citations 12

Authors

E Huberman

C Weeks

A Herrmann

M Callaham

T Slaga

Affiliations

Soon will be listed here.

Abstract

Polyamine levels were evaluated in human HL-60 promyelocytic leukemia cells after treatment with inducers of terminal differentiation. Differentiation in these cells was determined by increases in the percentage of morphologically mature cells and in lysozyme activity. Treatment of the HL-60 cells with phorbol 12-myristate-13-acetate (PMA), phorbol 12,13-didecanoate or other inducers of terminal differentiation such as dimethylsulfoxide and retinoic acid resulted in increased levels of putrescine. However, no increase in putrescine could be detected after PMA treatment of a HL-60 cell variant that exhibited a decreased susceptibility to PMA-induced terminal differentiation. Similarly, no increase in putrescine was observed with two non-tumor-promoters (phorbol 12,13-diacetate and 4-O-methyl-PMA) or with anthralin, a non-phorbol tumor promoter. In addition to enhancing putrescine levels, PMA also increased the amount of spermidine and decreased the amount of spermine. The increase in putrescine and spermidine preceded the expression of the various differentiation markers. Unlike the changes observed in the polyamine levels after PMA treatment, the activities of ornithine and S-adenosylmethionine decarboxylases, which are polyamine biosynthetic enzymes, did not significantly change. alpha-Methylornithine and alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone), which are inhibitors of the polyamine biosynthetic enzymes, did not affect differentiation in control or PMA-treated cells. Because of these observations, we suggest that the change in polyamine levels involve biochemical pathways other than the known biosynthetic ones. By-products of these pathways may perhaps be the controlling factors involved in the induction of terminal differentiation in the HL-60 and other cell types as well.

Citing Articles

New aspects in the synthesis and secretion of lysozyme by cultured human monocyte cell lines.

Helal R, Melzig M In Vitro Cell Dev Biol Anim. 2010; 46(6):492-6.

PMID: 20174882 DOI: 10.1007/s11626-010-9273-7.

Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies.

Fleck R, Romero-Steiner S, Nahm M Clin Diagn Lab Immunol. 2005; 12(1):19-27.

PMID: 15642980 PMC: 540204. DOI: 10.1128/CDLI.12.1.19-27.2005.

Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells.

Solanki V, Slaga T, Callaham M, Huberman E Proc Natl Acad Sci U S A. 1981; 78(3):1722-5.

PMID: 6940185 PMC: 319205. DOI: 10.1073/pnas.78.3.1722.

alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.

Weeks C, Herrmann A, Nelson F, Slaga T Proc Natl Acad Sci U S A. 1982; 79(19):6028-32.

PMID: 6821130 PMC: 347045. DOI: 10.1073/pnas.79.19.6028.

Phorbol esters rapidly stimulate amiloride-sensitive Na+/H+ exchange in a human leukemic cell line.

Besterman J, Cuatrecasas P J Cell Biol. 1984; 99(1 Pt 1):340-3.

PMID: 6330130 PMC: 2275640. DOI: 10.1083/jcb.99.1.340.

References

Huberman E, Callaham M . Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci U S A. 1979; 76(3):1293-7. PMC: 383237. DOI: 10.1073/pnas.76.3.1293. View

Nagasawa K, Mak T . Phorbol esters induce differentiation in human malignant T lymphoblasts. Proc Natl Acad Sci U S A. 1980; 77(5):2964-8. PMC: 349527. DOI: 10.1073/pnas.77.5.2964. View

BERENBLUM I . A re-evaluation of the concept of cocarciongenesis. Prog Exp Tumor Res. 1969; 11:21-30. DOI: 10.1159/000391387. View

WILLIAMS-ASHMAN H, Schenone A . Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases. Biochem Biophys Res Commun. 1972; 46(1):288-95. DOI: 10.1016/0006-291x(72)90661-4. View

Boutwell R . The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol. 1974; 2(4):419-43. DOI: 10.3109/10408447309025704. View

Newton N, Weeks C . Inhibitors of polyamine biosynthesis. 1. Alpha-methyl-(plus or minus)-ornithine, an inhibitor of ornithine decarboxylase. J Med Chem. 1974; 17(4):447-51. DOI: 10.1021/jm00250a016. View

KLUGE N, Gaedicke G, Steinheider G, Dube S, Ostertag W . Globin synthesis in Friend-erythroleukemia mouse cells in protein- and lipid-free medium. Effects of dimethyl-sulfoxide, iron and erythropoietin. Exp Cell Res. 1974; 88(2):257-62. DOI: 10.1016/0014-4827(74)90239-0. View

OBrien T, Simsiman R, Boutwell R . Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res. 1975; 35(9):2426-33. View

Stanley E, Hansen G, Woodcock J, Metcalf D . Colony stimulating factor and the regulation of granulopoiesis and macrophage production. Fed Proc. 1975; 34(13):2272-8. View

10.

Mamont P, Bohlen P, McCann P, Bey P, Schuber F, Tardif C . Alpha-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in culture. Proc Natl Acad Sci U S A. 1976; 73(5):1626-30. PMC: 430352. DOI: 10.1073/pnas.73.5.1626. View

11.

Yuspa S, Lichti U, Ben T, Patterson E, Hennings H, Slaga T . Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature. 1976; 262(5567):402-4. DOI: 10.1038/262402a0. View

12.

Holtta E . Oxidation of spermidine and spermine in rat liver: purification and properties of polyamine oxidase. Biochemistry. 1977; 16(1):91-100. DOI: 10.1021/bi00620a015. View

13.

Newton N . Inhibitors of polyamine biosynthesis. 4. Effects of alpha-methyl-(+/-)-ornithine and methylglyoxal bis(guanylhydrazone) on growth and polyamine content of L1210 leukemic cells of mice. J Med Chem. 1977; 20(2):249-53. DOI: 10.1021/jm00212a012. View

14.

Krystosek A, Sachs L . Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell. 1976; 9(4 PT 2):675-84. DOI: 10.1016/0092-8674(76)90131-8. View

15.

Cohen R, Pacifici M, Rubinstein N, Biehl J, Holtzer H . Effect of a tumour promoter on myogenesis. Nature. 1977; 266(5602):538-40. DOI: 10.1038/266538a0. View

16.

Rovera G, OBrien T, Diamond L . Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 1977; 74(7):2894-8. PMC: 431336. DOI: 10.1073/pnas.74.7.2894. View

17.

Yamasaki H, Fibach E, Nudel U, Weinstein I, Rifkind R, Marks P . Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 1977; 74(8):3451-5. PMC: 431603. DOI: 10.1073/pnas.74.8.3451. View

18.

Lichti U, Slaga T, Ben T, Patterson E, Hennings H, Yuspa S . Dissociation of tumor promoter-stimulated ornithine decarboxylase activity and DNA synthesis in mouse epidermis in vivo and in vitro by fluocinolone acetonide, a tumor-promotion inhibitor. Proc Natl Acad Sci U S A. 1977; 74(9):3908-12. PMC: 431781. DOI: 10.1073/pnas.74.9.3908. View

19.

Pacifici M, Holtzer H . Effects of a tumor-promoting agent on chondrogenesis. Am J Anat. 1977; 150(1):207-12. DOI: 10.1002/aja.1001500116. View

20.

Van Duuren B, Segal A, Tseng S, Rusch G, Loewengart G, Mate U . Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone). J Med Chem. 1978; 21(1):26-31. DOI: 10.1021/jm00199a005. View